

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NIK/NF-kappaB signaling (GO:0038061) | 7.97815757 |
| 2 | regulation of T-helper 1 cell differentiation (GO:0045625) | 6.32026413 |
| 3 | ribosomal small subunit biogenesis (GO:0042274) | 6.12277081 |
| 4 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 6.05933500 |
| 5 | viral transcription (GO:0019083) | 6.00455519 |
| 6 | positive regulation of natural killer cell differentiation (GO:0032825) | 5.84139786 |
| 7 | translational termination (GO:0006415) | 5.80801167 |
| 8 | maturation of SSU-rRNA (GO:0030490) | 5.79368738 |
| 9 | regulation of activation of Janus kinase activity (GO:0010533) | 5.51300080 |
| 10 | regulation of hypersensitivity (GO:0002883) | 5.51019634 |
| 11 | regulation of T-helper 2 cell differentiation (GO:0045628) | 5.39647640 |
| 12 | regulation of RIG-I signaling pathway (GO:0039535) | 5.23639078 |
| 13 | myeloid dendritic cell differentiation (GO:0043011) | 5.17051324 |
| 14 | positive regulation of T-helper cell differentiation (GO:0045624) | 5.12891238 |
| 15 | T-helper 1 type immune response (GO:0042088) | 5.10229664 |
| 16 | negative thymic T cell selection (GO:0045060) | 5.03878474 |
| 17 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.95341362 |
| 18 | ribosomal small subunit assembly (GO:0000028) | 4.95003244 |
| 19 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.94922226 |
| 20 | positive regulation of antigen processing and presentation (GO:0002579) | 4.93980042 |
| 21 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.91409175 |
| 22 | cotranslational protein targeting to membrane (GO:0006613) | 4.91151840 |
| 23 | chaperone-mediated protein transport (GO:0072321) | 4.86598253 |
| 24 | positive regulation of interleukin-12 production (GO:0032735) | 4.86050057 |
| 25 | neutrophil activation involved in immune response (GO:0002283) | 4.85955303 |
| 26 | translational elongation (GO:0006414) | 4.83961928 |
| 27 | protein targeting to ER (GO:0045047) | 4.83597958 |
| 28 | positive regulation of protein homooligomerization (GO:0032464) | 4.78279435 |
| 29 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 4.74574672 |
| 30 | T-helper cell differentiation (GO:0042093) | 4.74574672 |
| 31 | protein complex biogenesis (GO:0070271) | 4.73743428 |
| 32 | neutrophil activation (GO:0042119) | 4.73733218 |
| 33 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.72519554 |
| 34 | natural killer cell mediated immunity (GO:0002228) | 4.72519554 |
| 35 | negative T cell selection (GO:0043383) | 4.64973084 |
| 36 | ATP synthesis coupled proton transport (GO:0015986) | 4.62024647 |
| 37 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.62024647 |
| 38 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.61786198 |
| 39 | protein localization to endoplasmic reticulum (GO:0070972) | 4.61642017 |
| 40 | myeloid dendritic cell activation (GO:0001773) | 4.59646700 |
| 41 | positive regulation of type 2 immune response (GO:0002830) | 4.57359836 |
| 42 | behavioral response to nicotine (GO:0035095) | 4.55828269 |
| 43 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 4.54280235 |
| 44 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 4.50398773 |
| 45 | viral life cycle (GO:0019058) | 4.49369810 |
| 46 | granulocyte activation (GO:0036230) | 4.47964911 |
| 47 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.42590909 |
| 48 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.42590909 |
| 49 | NADH dehydrogenase complex assembly (GO:0010257) | 4.42590909 |
| 50 | regulation of T cell tolerance induction (GO:0002664) | 4.40086711 |
| 51 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.39262702 |
| 52 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.36611830 |
| 53 | response to prostaglandin E (GO:0034695) | 4.36264826 |
| 54 | regulation of antigen processing and presentation (GO:0002577) | 4.36235114 |
| 55 | cellular protein complex disassembly (GO:0043624) | 4.34230491 |
| 56 | regulation of immunoglobulin secretion (GO:0051023) | 4.31597790 |
| 57 | regulation of memory T cell differentiation (GO:0043380) | 4.30359071 |
| 58 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.27540566 |
| 59 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 4.15035655 |
| 60 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 4.15035655 |
| 61 | dendritic cell differentiation (GO:0097028) | 4.14466990 |
| 62 | regulation of natural killer cell differentiation (GO:0032823) | 4.14112964 |
| 63 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.12935385 |
| 64 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 4.10875702 |
| 65 | alpha-beta T cell activation involved in immune response (GO:0002287) | 4.10875702 |
| 66 | T cell differentiation involved in immune response (GO:0002292) | 4.10875702 |
| 67 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.07839341 |
| 68 | regulation of T-helper cell differentiation (GO:0045622) | 4.03256436 |
| 69 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.02361245 |
| 70 | ribosomal large subunit biogenesis (GO:0042273) | 3.98814507 |
| 71 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.98008318 |
| 72 | positive regulation of T cell cytokine production (GO:0002726) | 3.95427470 |
| 73 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.94029500 |
| 74 | electron transport chain (GO:0022900) | 3.93363442 |
| 75 | respiratory electron transport chain (GO:0022904) | 3.92126162 |
| 76 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 3.90314453 |
| 77 | dendritic cell migration (GO:0036336) | 3.89866523 |
| 78 | dendritic cell chemotaxis (GO:0002407) | 3.88946326 |
| 79 | growth hormone receptor signaling pathway (GO:0060396) | 3.87105829 |
| 80 | cytochrome complex assembly (GO:0017004) | 3.86118243 |
| 81 | translational initiation (GO:0006413) | 3.84254353 |
| 82 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.83877941 |
| 83 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.81629656 |
| 84 | protein-cofactor linkage (GO:0018065) | 3.80858080 |
| 85 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.80783132 |
| 86 | protein complex disassembly (GO:0043241) | 3.80413139 |
| 87 | interferon-gamma secretion (GO:0072643) | 3.79301239 |
| 88 | respiratory chain complex IV assembly (GO:0008535) | 3.79039928 |
| 89 | type I interferon signaling pathway (GO:0060337) | 3.73373644 |
| 90 | cellular response to type I interferon (GO:0071357) | 3.73373644 |
| 91 | regulation of mitochondrial translation (GO:0070129) | 3.69130174 |
| 92 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.68797219 |
| 93 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.68797219 |
| 94 | response to type I interferon (GO:0034340) | 3.64810366 |
| 95 | pseudouridine synthesis (GO:0001522) | 3.64454789 |
| 96 | protein neddylation (GO:0045116) | 3.63955051 |
| 97 | T cell selection (GO:0045058) | 3.63937435 |
| 98 | response to muramyl dipeptide (GO:0032495) | 3.62054610 |
| 99 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.60941243 |
| 100 | cellular response to zinc ion (GO:0071294) | 3.60250868 |
| 101 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.58229471 |
| 102 | termination of RNA polymerase III transcription (GO:0006386) | 3.58229471 |
| 103 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.55959017 |
| 104 | positive regulation of protein oligomerization (GO:0032461) | 3.55912524 |
| 105 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.54324388 |
| 106 | macromolecular complex disassembly (GO:0032984) | 3.52108817 |
| 107 | regulation of T-helper 1 type immune response (GO:0002825) | 3.51665285 |
| 108 | regulation of interleukin-12 production (GO:0032655) | 3.51391131 |
| 109 | translation (GO:0006412) | 3.51380668 |
| 110 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.49608726 |
| 111 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 3.46626955 |
| 112 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.44140835 |
| 113 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.43568687 |
| 114 | positive regulation of interleukin-2 production (GO:0032743) | 3.43424824 |
| 115 | cellular component biogenesis (GO:0044085) | 3.42902809 |
| 116 | resolution of meiotic recombination intermediates (GO:0000712) | 3.42888047 |
| 117 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.40957535 |
| 118 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.40322161 |
| 119 | thymic T cell selection (GO:0045061) | 3.39878089 |
| 120 | T cell activation involved in immune response (GO:0002286) | 3.38875745 |
| 121 | monocyte chemotaxis (GO:0002548) | 3.38083398 |
| 122 | positive regulation of humoral immune response (GO:0002922) | 3.37479386 |
| 123 | positive regulation of activated T cell proliferation (GO:0042104) | 3.36594705 |
| 124 | positive regulation of pseudopodium assembly (GO:0031274) | 3.36211553 |
| 125 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 3.36006351 |
| 126 | rRNA modification (GO:0000154) | 3.35615182 |
| 127 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.35134576 |
| 128 | platelet dense granule organization (GO:0060155) | 3.33226151 |
| 129 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.32694529 |
| 130 | regulation of tolerance induction (GO:0002643) | 3.32379518 |
| 131 | eosinophil chemotaxis (GO:0048245) | 3.31174794 |
| 132 | leukocyte mediated cytotoxicity (GO:0001909) | 3.31151811 |
| 133 | response to pheromone (GO:0019236) | 3.30632514 |
| 134 | cellular response to growth hormone stimulus (GO:0071378) | 3.27127535 |
| 135 | tRNA processing (GO:0008033) | 3.27099091 |
| 136 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.25332382 |
| 137 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.25332382 |
| 138 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.22275752 |
| 139 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.22194591 |
| 140 | peptidyl-histidine modification (GO:0018202) | 3.21079782 |
| 141 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.20627656 |
| 142 | base-excision repair, AP site formation (GO:0006285) | 3.20385716 |
| 143 | aggressive behavior (GO:0002118) | 3.18663429 |
| 144 | male meiosis I (GO:0007141) | 3.17089875 |
| 145 | response to prostaglandin (GO:0034694) | 3.16390437 |
| 146 | protein targeting to membrane (GO:0006612) | 3.16144022 |
| 147 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.16091940 |
| 148 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.15067746 |
| 149 | negative regulation of interleukin-17 production (GO:0032700) | 3.11306587 |
| 150 | lymphocyte migration (GO:0072676) | 3.10378680 |
| 151 | lymphocyte mediated immunity (GO:0002449) | 3.10072958 |
| 152 | negative regulation of necroptotic process (GO:0060546) | 3.09487282 |
| 153 | intracellular protein transmembrane import (GO:0044743) | 3.06538595 |
| 154 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.06162388 |
| 155 | alpha-beta T cell activation (GO:0046631) | 3.04750415 |
| 156 | negative regulation of viral genome replication (GO:0045071) | 3.04707153 |
| 157 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.04541026 |
| 158 | positive regulation of interleukin-17 production (GO:0032740) | 3.03259319 |
| 159 | desmosome organization (GO:0002934) | 3.02751827 |
| 160 | regulation of necroptotic process (GO:0060544) | 3.01789516 |
| 161 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.00914184 |
| 162 | positive regulation of T cell apoptotic process (GO:0070234) | 3.00823705 |
| 163 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.99086074 |
| 164 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.99082669 |
| 165 | striated muscle atrophy (GO:0014891) | 2.98516616 |
| 166 | mRNA catabolic process (GO:0006402) | 2.98160744 |
| 167 | hydrogen ion transmembrane transport (GO:1902600) | 2.92817486 |
| 168 | protein targeting to mitochondrion (GO:0006626) | 2.86662236 |
| 169 | meiosis I (GO:0007127) | 2.85695657 |
| 170 | meiotic chromosome segregation (GO:0045132) | 2.85120057 |
| 171 | negative regulation of response to food (GO:0032096) | 2.83532703 |
| 172 | negative regulation of appetite (GO:0032099) | 2.83532703 |
| 173 | DNA deamination (GO:0045006) | 2.83371808 |
| 174 | nephron tubule morphogenesis (GO:0072078) | 2.83243714 |
| 175 | nephron epithelium morphogenesis (GO:0072088) | 2.83243714 |
| 176 | rRNA processing (GO:0006364) | 2.80881982 |
| 177 | tRNA modification (GO:0006400) | 2.80612004 |
| 178 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.79120806 |
| 179 | rRNA methylation (GO:0031167) | 2.78076124 |
| 180 | RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502) | 2.76917513 |
| 181 | nonmotile primary cilium assembly (GO:0035058) | 2.75456213 |
| 182 | establishment of protein localization to mitochondrion (GO:0072655) | 2.75423881 |
| 183 | RNA catabolic process (GO:0006401) | 2.74279533 |
| 184 | cellular response to ATP (GO:0071318) | 2.73422037 |
| 185 | positive regulation of gastrulation (GO:2000543) | 2.72738419 |
| 186 | ATP biosynthetic process (GO:0006754) | 2.72204825 |
| 187 | rRNA metabolic process (GO:0016072) | 2.69438504 |
| 188 | tRNA metabolic process (GO:0006399) | 2.69260597 |
| 189 | pattern specification involved in kidney development (GO:0061004) | 2.69101234 |
| 190 | mannosylation (GO:0097502) | 2.65630705 |
| 191 | protein localization to mitochondrion (GO:0070585) | 2.64668432 |
| 192 | proton transport (GO:0015992) | 2.62056514 |
| 193 | axoneme assembly (GO:0035082) | 2.61661971 |
| 194 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.61538828 |
| 195 | ubiquinone biosynthetic process (GO:0006744) | 2.61473177 |
| 196 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.60163109 |
| 197 | GPI anchor biosynthetic process (GO:0006506) | 2.59740918 |
| 198 | hydrogen transport (GO:0006818) | 2.59524855 |
| 199 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.59025625 |
| 200 | deoxyribonucleotide catabolic process (GO:0009264) | 2.58964812 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 8.40142548 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.34677240 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.69210278 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.66134002 |
| 5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.86424760 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.51079128 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.35267982 |
| 8 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.12290596 |
| 9 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.06024609 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.00502361 |
| 11 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.99416523 |
| 12 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.59287315 |
| 13 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.45582016 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.36775888 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.32990974 |
| 16 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.22446942 |
| 17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.10889587 |
| 18 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.03003032 |
| 19 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.78516954 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.74399642 |
| 21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.72802100 |
| 22 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.61019363 |
| 23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.58335359 |
| 24 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.52932977 |
| 25 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.43353539 |
| 26 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.32771225 |
| 27 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.27464772 |
| 28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.20896319 |
| 29 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.19465477 |
| 30 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.16707549 |
| 31 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.12035087 |
| 32 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.11137809 |
| 33 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.09690873 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.99943147 |
| 35 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.99912333 |
| 36 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.98820539 |
| 37 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.98227273 |
| 38 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.97091218 |
| 39 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.96424518 |
| 40 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.92737301 |
| 41 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.91778276 |
| 42 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.91070959 |
| 43 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.89878391 |
| 44 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.87463676 |
| 45 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.86276848 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.85253922 |
| 47 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.83273085 |
| 48 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.81556969 |
| 49 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.78446451 |
| 50 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.77766283 |
| 51 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.75846726 |
| 52 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.70773280 |
| 53 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.68575473 |
| 54 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.59680911 |
| 55 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.55939288 |
| 56 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.54431788 |
| 57 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.51713172 |
| 58 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.51597931 |
| 59 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.50593333 |
| 60 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.49930115 |
| 61 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.48251579 |
| 62 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.46138854 |
| 63 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.43954068 |
| 64 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.36619183 |
| 65 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.36479018 |
| 66 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.32189420 |
| 67 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.31990517 |
| 68 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.31848174 |
| 69 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.31648729 |
| 70 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.31499335 |
| 71 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.30547105 |
| 72 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.29909260 |
| 73 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.29902868 |
| 74 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.29413981 |
| 75 | GATA1_22025678_ChIP-Seq_K562_Human | 1.29143080 |
| 76 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.28418869 |
| 77 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27112894 |
| 78 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.26919424 |
| 79 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24944508 |
| 80 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.24322392 |
| 81 | ERA_21632823_ChIP-Seq_H3396_Human | 1.23999385 |
| 82 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.23348185 |
| 83 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.20531180 |
| 84 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.19973406 |
| 85 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.19007246 |
| 86 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.15905397 |
| 87 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.15467669 |
| 88 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.15045410 |
| 89 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.14564395 |
| 90 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.13871322 |
| 91 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.13871322 |
| 92 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.13616524 |
| 93 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13198646 |
| 94 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.12711909 |
| 95 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.11556261 |
| 96 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10793925 |
| 97 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.10276595 |
| 98 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.10045864 |
| 99 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.09966484 |
| 100 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.09925070 |
| 101 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.08967957 |
| 102 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.08208184 |
| 103 | P68_20966046_ChIP-Seq_HELA_Human | 1.08088737 |
| 104 | EWS_26573619_Chip-Seq_HEK293_Human | 1.06063855 |
| 105 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05101301 |
| 106 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.05035852 |
| 107 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.04980925 |
| 108 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.04949589 |
| 109 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.03055871 |
| 110 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.03031982 |
| 111 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.02217337 |
| 112 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.01235269 |
| 113 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.01226967 |
| 114 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.00684038 |
| 115 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.00394846 |
| 116 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.99224469 |
| 117 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99118607 |
| 118 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.99042345 |
| 119 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.98232375 |
| 120 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98148117 |
| 121 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.98038214 |
| 122 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.97597394 |
| 123 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.97591638 |
| 124 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.96491474 |
| 125 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.96472323 |
| 126 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.96181317 |
| 127 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.95940008 |
| 128 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.95905495 |
| 129 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.94900550 |
| 130 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.94900550 |
| 131 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.94221240 |
| 132 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.94067734 |
| 133 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.94020518 |
| 134 | MAF_26560356_Chip-Seq_TH1_Human | 0.93948047 |
| 135 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.93185966 |
| 136 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.92500599 |
| 137 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.92063878 |
| 138 | MYB_26560356_Chip-Seq_TH2_Human | 0.91962066 |
| 139 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91557807 |
| 140 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.90875972 |
| 141 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.90591616 |
| 142 | P300_19829295_ChIP-Seq_ESCs_Human | 0.90574198 |
| 143 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.89903277 |
| 144 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.89799837 |
| 145 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.89108194 |
| 146 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.89078799 |
| 147 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.88476450 |
| 148 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.87141621 |
| 149 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.85927591 |
| 150 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.85676939 |
| 151 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.85529021 |
| 152 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.85296447 |
| 153 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84859376 |
| 154 | NCOR_22424771_ChIP-Seq_293T_Human | 0.84505323 |
| 155 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.84425462 |
| 156 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.84126763 |
| 157 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.83270130 |
| 158 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.82369034 |
| 159 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.82273770 |
| 160 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82064858 |
| 161 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.81481854 |
| 162 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.81471797 |
| 163 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80376900 |
| 164 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.80348781 |
| 165 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.80280154 |
| 166 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.78861667 |
| 167 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78604653 |
| 168 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.76887642 |
| 169 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.75214381 |
| 170 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74654400 |
| 171 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.73784297 |
| 172 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.73362742 |
| 173 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.73192069 |
| 174 | MYB_26560356_Chip-Seq_TH1_Human | 0.71838151 |
| 175 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.71757737 |
| 176 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.71707667 |
| 177 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.71400855 |
| 178 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71380960 |
| 179 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.70952447 |
| 180 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.70631214 |
| 181 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.69863891 |
| 182 | AR_25329375_ChIP-Seq_VCAP_Human | 0.69554710 |
| 183 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.68315235 |
| 184 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.68199831 |
| 185 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.67756041 |
| 186 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.67351417 |
| 187 | CJUN_26792858_Chip-Seq_BT549_Human | 0.67344984 |
| 188 | VDR_22108803_ChIP-Seq_LS180_Human | 0.66871704 |
| 189 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.66572034 |
| 190 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.65673220 |
| 191 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.64944854 |
| 192 | RXR_22108803_ChIP-Seq_LS180_Human | 0.64766311 |
| 193 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.64116384 |
| 194 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.63741376 |
| 195 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.63237018 |
| 196 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.62849653 |
| 197 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.62562231 |
| 198 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.62200450 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002163_abnormal_gland_morphology | 5.88931803 |
| 2 | MP0001348_abnormal_lacrimal_gland | 5.25607575 |
| 3 | MP0006292_abnormal_olfactory_placode | 4.91380884 |
| 4 | MP0001346_abnormal_lacrimal_gland | 4.67357983 |
| 5 | MP0002254_reproductive_system_inflammat | 4.51951691 |
| 6 | MP0002138_abnormal_hepatobiliary_system | 4.40300171 |
| 7 | MP0000685_abnormal_immune_system | 4.34075586 |
| 8 | MP0009379_abnormal_foot_pigmentation | 4.33311512 |
| 9 | MP0001835_abnormal_antigen_presentation | 4.32062766 |
| 10 | MP0002009_preneoplasia | 3.66727999 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 3.47735473 |
| 12 | MP0004510_myositis | 3.35097739 |
| 13 | MP0005379_endocrine/exocrine_gland_phen | 3.24417505 |
| 14 | MP0002166_altered_tumor_susceptibility | 3.13369308 |
| 15 | MP0001790_abnormal_immune_system | 2.91308505 |
| 16 | MP0005387_immune_system_phenotype | 2.91308505 |
| 17 | MP0002006_tumorigenesis | 2.77633858 |
| 18 | MP0005310_abnormal_salivary_gland | 2.72621455 |
| 19 | MP0001986_abnormal_taste_sensitivity | 2.49918956 |
| 20 | MP0009785_altered_susceptibility_to | 2.41592011 |
| 21 | MP0002653_abnormal_ependyma_morphology | 2.39388748 |
| 22 | MP0001905_abnormal_dopamine_level | 2.37362339 |
| 23 | MP0002736_abnormal_nociception_after | 2.32083178 |
| 24 | MP0002796_impaired_skin_barrier | 2.31045866 |
| 25 | MP0003436_decreased_susceptibility_to | 2.30390293 |
| 26 | MP0008789_abnormal_olfactory_epithelium | 2.25504228 |
| 27 | MP0004147_increased_porphyrin_level | 2.24767867 |
| 28 | MP0002638_abnormal_pupillary_reflex | 2.23954024 |
| 29 | MP0010234_abnormal_vibrissa_follicle | 2.20930277 |
| 30 | MP0002277_abnormal_respiratory_mucosa | 2.16897491 |
| 31 | MP0005000_abnormal_immune_tolerance | 2.13093614 |
| 32 | MP0005671_abnormal_response_to | 2.12906575 |
| 33 | MP0003941_abnormal_skin_development | 2.09729457 |
| 34 | MP0003136_yellow_coat_color | 2.09354655 |
| 35 | MP0002876_abnormal_thyroid_physiology | 2.06415370 |
| 36 | MP0008877_abnormal_DNA_methylation | 1.97546165 |
| 37 | MP0002837_dystrophic_cardiac_calcinosis | 1.97084419 |
| 38 | MP0004133_heterotaxia | 1.95042044 |
| 39 | MP0006072_abnormal_retinal_apoptosis | 1.90136947 |
| 40 | MP0008875_abnormal_xenobiotic_pharmacok | 1.89429273 |
| 41 | MP0003011_delayed_dark_adaptation | 1.88237388 |
| 42 | MP0001188_hyperpigmentation | 1.84874682 |
| 43 | MP0001800_abnormal_humoral_immune | 1.84136709 |
| 44 | MP0006036_abnormal_mitochondrial_physio | 1.76451581 |
| 45 | MP0000631_abnormal_neuroendocrine_gland | 1.74546565 |
| 46 | MP0005423_abnormal_somatic_nervous | 1.73504112 |
| 47 | MP0002095_abnormal_skin_pigmentation | 1.73262179 |
| 48 | MP0002723_abnormal_immune_serum | 1.72869549 |
| 49 | MP0002452_abnormal_antigen_presenting | 1.71716731 |
| 50 | MP0003806_abnormal_nucleotide_metabolis | 1.68467254 |
| 51 | MP0005025_abnormal_response_to | 1.67377457 |
| 52 | MP0001853_heart_inflammation | 1.64810815 |
| 53 | MP0004142_abnormal_muscle_tone | 1.63046740 |
| 54 | MP0004947_skin_inflammation | 1.62364498 |
| 55 | MP0001819_abnormal_immune_cell | 1.56253809 |
| 56 | MP0010386_abnormal_urinary_bladder | 1.55374177 |
| 57 | MP0003186_abnormal_redox_activity | 1.55218461 |
| 58 | MP0003693_abnormal_embryo_hatching | 1.55001378 |
| 59 | MP0005394_taste/olfaction_phenotype | 1.53377258 |
| 60 | MP0005499_abnormal_olfactory_system | 1.53377258 |
| 61 | MP0003718_maternal_effect | 1.52998018 |
| 62 | MP0005646_abnormal_pituitary_gland | 1.52850145 |
| 63 | MP0002877_abnormal_melanocyte_morpholog | 1.52153523 |
| 64 | MP0002160_abnormal_reproductive_system | 1.51062468 |
| 65 | MP0002420_abnormal_adaptive_immunity | 1.48668799 |
| 66 | MP0005551_abnormal_eye_electrophysiolog | 1.47933589 |
| 67 | MP0001293_anophthalmia | 1.46536149 |
| 68 | MP0002419_abnormal_innate_immunity | 1.40663158 |
| 69 | MP0003880_abnormal_central_pattern | 1.39057270 |
| 70 | MP0002938_white_spotting | 1.38316087 |
| 71 | MP0003453_abnormal_keratinocyte_physiol | 1.34759924 |
| 72 | MP0005645_abnormal_hypothalamus_physiol | 1.34399495 |
| 73 | MP0004885_abnormal_endolymph | 1.32217674 |
| 74 | MP0002132_abnormal_respiratory_system | 1.31710000 |
| 75 | MP0009278_abnormal_bone_marrow | 1.30002108 |
| 76 | MP0005253_abnormal_eye_physiology | 1.25754417 |
| 77 | MP0003121_genomic_imprinting | 1.24471949 |
| 78 | MP0010030_abnormal_orbit_morphology | 1.20522887 |
| 79 | MP0005501_abnormal_skin_physiology | 1.20258246 |
| 80 | MP0001764_abnormal_homeostasis | 1.19643747 |
| 81 | MP0003123_paternal_imprinting | 1.17179617 |
| 82 | MP0002735_abnormal_chemical_nociception | 1.16553142 |
| 83 | MP0006082_CNS_inflammation | 1.16099226 |
| 84 | MP0008058_abnormal_DNA_repair | 1.13237230 |
| 85 | MP0002210_abnormal_sex_determination | 1.13083890 |
| 86 | MP0000716_abnormal_immune_system | 1.13005287 |
| 87 | MP0005389_reproductive_system_phenotype | 1.09975241 |
| 88 | MP0000372_irregular_coat_pigmentation | 1.09917022 |
| 89 | MP0005623_abnormal_meninges_morphology | 1.09470303 |
| 90 | MP0006276_abnormal_autonomic_nervous | 1.07972504 |
| 91 | MP0003122_maternal_imprinting | 1.06674245 |
| 92 | MP0001216_abnormal_epidermal_layer | 1.06516970 |
| 93 | MP0001502_abnormal_circadian_rhythm | 1.05520402 |
| 94 | MP0005377_hearing/vestibular/ear_phenot | 1.04681857 |
| 95 | MP0003878_abnormal_ear_physiology | 1.04681857 |
| 96 | MP0001529_abnormal_vocalization | 1.02883529 |
| 97 | MP0000015_abnormal_ear_pigmentation | 1.02155319 |
| 98 | MP0010094_abnormal_chromosome_stability | 1.01608252 |
| 99 | MP0002272_abnormal_nervous_system | 1.01575603 |
| 100 | MP0005195_abnormal_posterior_eye | 1.00144402 |
| 101 | MP0000049_abnormal_middle_ear | 1.00065192 |
| 102 | MP0006035_abnormal_mitochondrial_morpho | 0.98276008 |
| 103 | MP0002398_abnormal_bone_marrow | 0.98224843 |
| 104 | MP0000569_abnormal_digit_pigmentation | 0.98155086 |
| 105 | MP0003091_abnormal_cell_migration | 0.97158177 |
| 106 | MP0005171_absent_coat_pigmentation | 0.96747075 |
| 107 | MP0003763_abnormal_thymus_physiology | 0.96618826 |
| 108 | MP0001929_abnormal_gametogenesis | 0.94188920 |
| 109 | MP0000026_abnormal_inner_ear | 0.93277767 |
| 110 | MP0002557_abnormal_social/conspecific_i | 0.92851882 |
| 111 | MP0002405_respiratory_system_inflammati | 0.92761753 |
| 112 | MP0005076_abnormal_cell_differentiation | 0.92544440 |
| 113 | MP0003938_abnormal_ear_development | 0.91610479 |
| 114 | MP0002234_abnormal_pharynx_morphology | 0.91256654 |
| 115 | MP0001145_abnormal_male_reproductive | 0.90263319 |
| 116 | MP0009764_decreased_sensitivity_to | 0.89784966 |
| 117 | MP0003724_increased_susceptibility_to | 0.89576963 |
| 118 | MP0001970_abnormal_pain_threshold | 0.89320110 |
| 119 | MP0000653_abnormal_sex_gland | 0.87893415 |
| 120 | MP0002572_abnormal_emotion/affect_behav | 0.87870988 |
| 121 | MP0000627_abnormal_mammary_gland | 0.86623887 |
| 122 | MP0005391_vision/eye_phenotype | 0.86096509 |
| 123 | MP0002822_catalepsy | 0.85991660 |
| 124 | MP0008872_abnormal_physiological_respon | 0.85747500 |
| 125 | MP0001286_abnormal_eye_development | 0.83434795 |
| 126 | MP0003698_abnormal_male_reproductive | 0.83132122 |
| 127 | MP0005332_abnormal_amino_acid | 0.82009079 |
| 128 | MP0001845_abnormal_inflammatory_respons | 0.81437030 |
| 129 | MP0003191_abnormal_cellular_cholesterol | 0.81187727 |
| 130 | MP0000538_abnormal_urinary_bladder | 0.81012581 |
| 131 | MP0005410_abnormal_fertilization | 0.80655577 |
| 132 | MP0004782_abnormal_surfactant_physiolog | 0.80435347 |
| 133 | MP0003315_abnormal_perineum_morphology | 0.80333156 |
| 134 | MP0001984_abnormal_olfaction | 0.80200824 |
| 135 | MP0002067_abnormal_sensory_capabilities | 0.79648371 |
| 136 | MP0004019_abnormal_vitamin_homeostasis | 0.79047802 |
| 137 | MP0001485_abnormal_pinna_reflex | 0.78787593 |
| 138 | MP0004381_abnormal_hair_follicle | 0.78045855 |
| 139 | MP0001881_abnormal_mammary_gland | 0.76497844 |
| 140 | MP0001873_stomach_inflammation | 0.76120485 |
| 141 | MP0004145_abnormal_muscle_electrophysio | 0.76114462 |
| 142 | MP0004742_abnormal_vestibular_system | 0.75983461 |
| 143 | MP0002429_abnormal_blood_cell | 0.74980138 |
| 144 | MP0000778_abnormal_nervous_system | 0.74931887 |
| 145 | MP0002752_abnormal_somatic_nervous | 0.74911838 |
| 146 | MP0001944_abnormal_pancreas_morphology | 0.74848975 |
| 147 | MP0003786_premature_aging | 0.74200476 |
| 148 | MP0010771_integument_phenotype | 0.71897271 |
| 149 | MP0005275_abnormal_skin_tensile | 0.69875664 |
| 150 | MP0009046_muscle_twitch | 0.68072881 |
| 151 | MP0001533_abnormal_skeleton_physiology | 0.68042170 |
| 152 | MP0003448_altered_tumor_morphology | 0.66814509 |
| 153 | MP0008469_abnormal_protein_level | 0.66809759 |
| 154 | MP0010678_abnormal_skin_adnexa | 0.65866553 |
| 155 | MP0001191_abnormal_skin_condition | 0.63819106 |
| 156 | MP0004185_abnormal_adipocyte_glucose | 0.63083405 |
| 157 | MP0000383_abnormal_hair_follicle | 0.60820192 |
| 158 | MP0002722_abnormal_immune_system | 0.60099340 |
| 159 | MP0002102_abnormal_ear_morphology | 0.59351341 |
| 160 | MP0003183_abnormal_peptide_metabolism | 0.58801906 |
| 161 | MP0004858_abnormal_nervous_system | 0.58214933 |
| 162 | MP0000613_abnormal_salivary_gland | 0.58107027 |
| 163 | MP0010155_abnormal_intestine_physiology | 0.57472238 |
| 164 | MP0003566_abnormal_cell_adhesion | 0.57102424 |
| 165 | MP0000858_altered_metastatic_potential | 0.52411013 |
| 166 | MP0003787_abnormal_imprinting | 0.52069110 |
| 167 | MP0001243_abnormal_dermal_layer | 0.50309260 |
| 168 | MP0000689_abnormal_spleen_morphology | 0.49414688 |
| 169 | MP0000367_abnormal_coat/_hair | 0.48657817 |
| 170 | MP0009745_abnormal_behavioral_response | 0.48546934 |
| 171 | MP0001968_abnormal_touch/_nociception | 0.47978058 |
| 172 | MP0004859_abnormal_synaptic_plasticity | 0.45904242 |
| 173 | MP0002295_abnormal_pulmonary_circulatio | 0.43908249 |
| 174 | MP0005174_abnormal_tail_pigmentation | 0.42853161 |
| 175 | MP0000681_abnormal_thyroid_gland | 0.42799901 |
| 176 | MP0000703_abnormal_thymus_morphology | 0.42331345 |
| 177 | MP0001765_abnormal_ion_homeostasis | 0.40177524 |
| 178 | MP0002060_abnormal_skin_morphology | 0.39466595 |
| 179 | MP0005367_renal/urinary_system_phenotyp | 0.38832010 |
| 180 | MP0000516_abnormal_urinary_system | 0.38832010 |
| 181 | MP0002098_abnormal_vibrissa_morphology | 0.37472967 |
| 182 | MP0009931_abnormal_skin_appearance | 0.37420390 |
| 183 | MP0000604_amyloidosis | 0.37304903 |
| 184 | MP0002998_abnormal_bone_remodeling | 0.34600413 |
| 185 | MP0001879_abnormal_lymphatic_vessel | 0.33905027 |
| 186 | MP0005084_abnormal_gallbladder_morpholo | 0.33731031 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased IgM level (HP:0003496) | 9.01157191 |
| 2 | Autoimmune thrombocytopenia (HP:0001973) | 7.03420588 |
| 3 | Optic neuritis (HP:0100653) | 5.00962756 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 5.00962756 |
| 5 | Hypergammaglobulinemia (HP:0010702) | 4.97123910 |
| 6 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.70555551 |
| 7 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.64162469 |
| 8 | Autoimmune hemolytic anemia (HP:0001890) | 4.60369405 |
| 9 | Orchitis (HP:0100796) | 4.38171647 |
| 10 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.27808101 |
| 11 | Parakeratosis (HP:0001036) | 4.20393034 |
| 12 | Mitochondrial inheritance (HP:0001427) | 4.14674343 |
| 13 | Abnormal number of erythroid precursors (HP:0012131) | 4.14058022 |
| 14 | Hypochromic anemia (HP:0001931) | 4.11575938 |
| 15 | Eosinophilia (HP:0001880) | 4.07352857 |
| 16 | Reticulocytopenia (HP:0001896) | 3.96286566 |
| 17 | Recurrent bacterial skin infections (HP:0005406) | 3.95056158 |
| 18 | Acute necrotizing encephalopathy (HP:0006965) | 3.91559169 |
| 19 | Vasculitis (HP:0002633) | 3.88704461 |
| 20 | Increased IgE level (HP:0003212) | 3.83176323 |
| 21 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.83097591 |
| 22 | Myositis (HP:0100614) | 3.77473116 |
| 23 | Renal Fanconi syndrome (HP:0001994) | 3.77276719 |
| 24 | Molar tooth sign on MRI (HP:0002419) | 3.76841514 |
| 25 | Abnormality of midbrain morphology (HP:0002418) | 3.76841514 |
| 26 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.74225091 |
| 27 | Hepatocellular necrosis (HP:0001404) | 3.73319489 |
| 28 | Increased hepatocellular lipid droplets (HP:0006565) | 3.72975529 |
| 29 | Recurrent fungal infections (HP:0002841) | 3.72030264 |
| 30 | Recurrent abscess formation (HP:0002722) | 3.64612494 |
| 31 | Eczematoid dermatitis (HP:0000976) | 3.63428425 |
| 32 | Anhidrosis (HP:0000970) | 3.61079608 |
| 33 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.59921958 |
| 34 | Mediastinal lymphadenopathy (HP:0100721) | 3.58418018 |
| 35 | Increased CSF lactate (HP:0002490) | 3.58124507 |
| 36 | Lipid accumulation in hepatocytes (HP:0006561) | 3.49596915 |
| 37 | Gastrointestinal infarctions (HP:0005244) | 3.48675360 |
| 38 | Lip pit (HP:0100267) | 3.46112488 |
| 39 | Acute encephalopathy (HP:0006846) | 3.41095529 |
| 40 | Tetraparesis (HP:0002273) | 3.39936263 |
| 41 | Granulocytopenia (HP:0001913) | 3.39079162 |
| 42 | Hepatic necrosis (HP:0002605) | 3.34153799 |
| 43 | Recurrent viral infections (HP:0004429) | 3.29327568 |
| 44 | Abnormality of T cell number (HP:0011839) | 3.27372414 |
| 45 | Chronic otitis media (HP:0000389) | 3.19298036 |
| 46 | Pancreatic cysts (HP:0001737) | 3.16363676 |
| 47 | Progressive macrocephaly (HP:0004481) | 3.13154297 |
| 48 | Congenital stationary night blindness (HP:0007642) | 3.12490748 |
| 49 | Porencephaly (HP:0002132) | 3.11802756 |
| 50 | Increased intramyocellular lipid droplets (HP:0012240) | 3.11710508 |
| 51 | Pancreatic fibrosis (HP:0100732) | 3.10668894 |
| 52 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.06389895 |
| 53 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.06389895 |
| 54 | Macrocytic anemia (HP:0001972) | 3.06161447 |
| 55 | Abnormality of eosinophils (HP:0001879) | 3.06068161 |
| 56 | Gangrene (HP:0100758) | 3.04054142 |
| 57 | Medial flaring of the eyebrow (HP:0010747) | 3.03797418 |
| 58 | Hypothermia (HP:0002045) | 3.03596380 |
| 59 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.98366611 |
| 60 | Pulmonary infiltrates (HP:0002113) | 2.93605391 |
| 61 | Abnormality of macrophages (HP:0004311) | 2.90582693 |
| 62 | Nephronophthisis (HP:0000090) | 2.86216741 |
| 63 | Pallor (HP:0000980) | 2.85169105 |
| 64 | Arterial thrombosis (HP:0004420) | 2.84007810 |
| 65 | Leukocytosis (HP:0001974) | 2.83941900 |
| 66 | Basal ganglia calcification (HP:0002135) | 2.79944751 |
| 67 | Exertional dyspnea (HP:0002875) | 2.76702672 |
| 68 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.74611546 |
| 69 | Joint swelling (HP:0001386) | 2.74197529 |
| 70 | Chronic hepatic failure (HP:0100626) | 2.73801557 |
| 71 | Increased muscle lipid content (HP:0009058) | 2.72628010 |
| 72 | Septo-optic dysplasia (HP:0100842) | 2.72368072 |
| 73 | Agammaglobulinemia (HP:0004432) | 2.71765301 |
| 74 | Urticaria (HP:0001025) | 2.66300798 |
| 75 | Keratoconjunctivitis sicca (HP:0001097) | 2.64889424 |
| 76 | Keratoconjunctivitis (HP:0001096) | 2.62718401 |
| 77 | Absent thumb (HP:0009777) | 2.59777589 |
| 78 | 3-Methylglutaconic aciduria (HP:0003535) | 2.59178683 |
| 79 | Erythema (HP:0010783) | 2.55106356 |
| 80 | Fatigue (HP:0012378) | 2.54883684 |
| 81 | Increased serum lactate (HP:0002151) | 2.51047222 |
| 82 | Periodontitis (HP:0000704) | 2.50756547 |
| 83 | Premature loss of primary teeth (HP:0006323) | 2.49144367 |
| 84 | True hermaphroditism (HP:0010459) | 2.47607302 |
| 85 | Cortical dysplasia (HP:0002539) | 2.47458635 |
| 86 | Recurrent skin infections (HP:0001581) | 2.47433317 |
| 87 | Vertebral compression fractures (HP:0002953) | 2.46519738 |
| 88 | Nasal polyposis (HP:0100582) | 2.45228737 |
| 89 | Panhypogammaglobulinemia (HP:0003139) | 2.44855285 |
| 90 | Methylmalonic acidemia (HP:0002912) | 2.43913758 |
| 91 | Abnormal drinking behavior (HP:0030082) | 2.42957461 |
| 92 | Polydipsia (HP:0001959) | 2.42957461 |
| 93 | Pendular nystagmus (HP:0012043) | 2.42664889 |
| 94 | Abnormality of renal resorption (HP:0011038) | 2.42458798 |
| 95 | Adrenal hypoplasia (HP:0000835) | 2.42033563 |
| 96 | Chronic sinusitis (HP:0011109) | 2.41973303 |
| 97 | Gait imbalance (HP:0002141) | 2.39173695 |
| 98 | Lactic acidosis (HP:0003128) | 2.38116121 |
| 99 | Rib fusion (HP:0000902) | 2.36622768 |
| 100 | Abnormality of the renal medulla (HP:0100957) | 2.36601374 |
| 101 | Prostate neoplasm (HP:0100787) | 2.36536960 |
| 102 | Congenital primary aphakia (HP:0007707) | 2.36028637 |
| 103 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.34788883 |
| 104 | Recurrent cutaneous fungal infections (HP:0011370) | 2.34788883 |
| 105 | Type I transferrin isoform profile (HP:0003642) | 2.34037336 |
| 106 | Hypohidrosis (HP:0000966) | 2.32887002 |
| 107 | Optic disc pallor (HP:0000543) | 2.32355824 |
| 108 | Methylmalonic aciduria (HP:0012120) | 2.31046058 |
| 109 | Exercise intolerance (HP:0003546) | 2.29914256 |
| 110 | Peritonitis (HP:0002586) | 2.29794669 |
| 111 | Hyperglycinemia (HP:0002154) | 2.26605537 |
| 112 | Asplenia (HP:0001746) | 2.26259735 |
| 113 | Nephrogenic diabetes insipidus (HP:0009806) | 2.25442364 |
| 114 | Sclerocornea (HP:0000647) | 2.22175364 |
| 115 | Myokymia (HP:0002411) | 2.21456428 |
| 116 | Congenital hepatic fibrosis (HP:0002612) | 2.21171797 |
| 117 | Respiratory difficulties (HP:0002880) | 2.20949701 |
| 118 | Thrombocytosis (HP:0001894) | 2.19103089 |
| 119 | Cerebral edema (HP:0002181) | 2.18811840 |
| 120 | Cleft eyelid (HP:0000625) | 2.18743676 |
| 121 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.18563363 |
| 122 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.18065216 |
| 123 | Hydroxyprolinuria (HP:0003080) | 2.15859330 |
| 124 | Abnormality of proline metabolism (HP:0010907) | 2.15859330 |
| 125 | Hypoplasia of the pons (HP:0012110) | 2.14870325 |
| 126 | Erythroderma (HP:0001019) | 2.11448918 |
| 127 | Conical tooth (HP:0000698) | 2.10218655 |
| 128 | Hyperthyroidism (HP:0000836) | 2.08773581 |
| 129 | Neutropenia (HP:0001875) | 2.08723498 |
| 130 | Encephalitis (HP:0002383) | 2.06488288 |
| 131 | Respiratory failure (HP:0002878) | 2.06305219 |
| 132 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.03706782 |
| 133 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.03706782 |
| 134 | Abnormal protein glycosylation (HP:0012346) | 2.03706782 |
| 135 | Abnormal glycosylation (HP:0012345) | 2.03706782 |
| 136 | Cerebral hemorrhage (HP:0001342) | 2.03021982 |
| 137 | B lymphocytopenia (HP:0010976) | 2.02086809 |
| 138 | Median cleft lip (HP:0000161) | 2.01261493 |
| 139 | Abnormality of the pons (HP:0007361) | 2.00355733 |
| 140 | Retinal dysplasia (HP:0007973) | 1.99574430 |
| 141 | Hemoptysis (HP:0002105) | 1.98896504 |
| 142 | Abnormality of B cell number (HP:0010975) | 1.98602688 |
| 143 | Hypertensive crisis (HP:0100735) | 1.97490270 |
| 144 | Colon cancer (HP:0003003) | 1.95489434 |
| 145 | Type 2 muscle fiber atrophy (HP:0003554) | 1.95412338 |
| 146 | Abnormality of T cell physiology (HP:0011840) | 1.95108230 |
| 147 | IgG deficiency (HP:0004315) | 1.94342150 |
| 148 | Meningitis (HP:0001287) | 1.92908765 |
| 149 | Obstructive lung disease (HP:0006536) | 1.92846403 |
| 150 | Chronic obstructive pulmonary disease (HP:0006510) | 1.92846403 |
| 151 | Vertigo (HP:0002321) | 1.91528285 |
| 152 | Bile duct proliferation (HP:0001408) | 1.91211286 |
| 153 | Abnormal biliary tract physiology (HP:0012439) | 1.91211286 |
| 154 | Ectropion (HP:0000656) | 1.90294014 |
| 155 | Muscle fiber atrophy (HP:0100295) | 1.89921986 |
| 156 | Limb dystonia (HP:0002451) | 1.88925643 |
| 157 | Lethargy (HP:0001254) | 1.88231915 |
| 158 | Polyuria (HP:0000103) | 1.87474714 |
| 159 | Testicular atrophy (HP:0000029) | 1.87055358 |
| 160 | Abnormality of DNA repair (HP:0003254) | 1.86981426 |
| 161 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.85410654 |
| 162 | Osteolytic defects of the hand bones (HP:0009699) | 1.85410654 |
| 163 | Enlarged kidneys (HP:0000105) | 1.85088076 |
| 164 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.85000845 |
| 165 | Anophthalmia (HP:0000528) | 1.84787910 |
| 166 | Abnormality of urine glucose concentration (HP:0011016) | 1.84450701 |
| 167 | Glycosuria (HP:0003076) | 1.84450701 |
| 168 | Cystic liver disease (HP:0006706) | 1.83910083 |
| 169 | Abnormality of the pericardium (HP:0001697) | 1.83723352 |
| 170 | IgA deficiency (HP:0002720) | 1.81047622 |
| 171 | Gingivitis (HP:0000230) | 1.80494406 |
| 172 | Abnormal hair whorl (HP:0010721) | 1.79804753 |
| 173 | Palpebral edema (HP:0100540) | 1.79269791 |
| 174 | Pruritus (HP:0000989) | 1.78645053 |
| 175 | Facial hemangioma (HP:0000329) | 1.77646881 |
| 176 | Hypercortisolism (HP:0001578) | 1.76532793 |
| 177 | Abnormality of the renal cortex (HP:0011035) | 1.76395723 |
| 178 | Abnormality of the nasal mucosa (HP:0000433) | 1.76091373 |
| 179 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.75463895 |
| 180 | Abnormality of the gastric mucosa (HP:0004295) | 1.74990833 |
| 181 | Optic nerve hypoplasia (HP:0000609) | 1.74634045 |
| 182 | Alveolar cell carcinoma (HP:0006519) | 1.74384625 |
| 183 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.74209427 |
| 184 | Colitis (HP:0002583) | 1.74098678 |
| 185 | Abnormality of the periventricular white matter (HP:0002518) | 1.74078201 |
| 186 | Sepsis (HP:0100806) | 1.72848868 |
| 187 | Male pseudohermaphroditism (HP:0000037) | 1.72817710 |
| 188 | Portal hypertension (HP:0001409) | 1.72796724 |
| 189 | CNS demyelination (HP:0007305) | 1.72465441 |
| 190 | Attenuation of retinal blood vessels (HP:0007843) | 1.72352686 |
| 191 | Aganglionic megacolon (HP:0002251) | 1.72243839 |
| 192 | Febrile seizures (HP:0002373) | 1.70968683 |
| 193 | Cerebral ischemia (HP:0002637) | 1.70830987 |
| 194 | Vaginal atresia (HP:0000148) | 1.70669003 |
| 195 | Amaurosis fugax (HP:0100576) | 1.70617986 |
| 196 | Facial diplegia (HP:0001349) | 1.69954082 |
| 197 | Abnormality of the hepatic vasculature (HP:0006707) | 1.69929300 |
| 198 | Microretrognathia (HP:0000308) | 1.69113443 |
| 199 | Genital tract atresia (HP:0001827) | 1.68862746 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 7.20194587 |
| 2 | MAP3K13 | 5.19501067 |
| 3 | BCR | 4.63412465 |
| 4 | IKBKB | 3.62834688 |
| 5 | TLK1 | 3.57705467 |
| 6 | ARAF | 3.35036136 |
| 7 | TYK2 | 3.22488400 |
| 8 | PIM2 | 3.13076557 |
| 9 | BCKDK | 3.11565599 |
| 10 | STK16 | 2.98893696 |
| 11 | TBK1 | 2.92096774 |
| 12 | TAOK3 | 2.87172050 |
| 13 | CHUK | 2.73929274 |
| 14 | JAK3 | 2.69398544 |
| 15 | VRK2 | 2.53341500 |
| 16 | TESK2 | 2.48907970 |
| 17 | IKBKE | 2.20352102 |
| 18 | WNK4 | 2.15236511 |
| 19 | BMPR2 | 2.14104418 |
| 20 | NUAK1 | 2.11902898 |
| 21 | GRK1 | 2.09669044 |
| 22 | CDC7 | 2.02638476 |
| 23 | MUSK | 2.00069411 |
| 24 | MAPK15 | 1.98508506 |
| 25 | RIPK4 | 1.91261709 |
| 26 | JAK1 | 1.81571975 |
| 27 | BUB1 | 1.76431380 |
| 28 | TESK1 | 1.69506627 |
| 29 | DYRK2 | 1.69263649 |
| 30 | PKN1 | 1.66061214 |
| 31 | MAP3K9 | 1.63805421 |
| 32 | IRAK4 | 1.60734264 |
| 33 | MAP4K2 | 1.53565673 |
| 34 | VRK1 | 1.50475732 |
| 35 | MST4 | 1.42898456 |
| 36 | PINK1 | 1.41807594 |
| 37 | CASK | 1.40504544 |
| 38 | SYK | 1.39169438 |
| 39 | PDK2 | 1.37195696 |
| 40 | PHKG1 | 1.35188381 |
| 41 | PHKG2 | 1.35188381 |
| 42 | BMPR1B | 1.33275653 |
| 43 | BRAF | 1.28679763 |
| 44 | NME2 | 1.27735634 |
| 45 | GRK7 | 1.20939306 |
| 46 | WNK3 | 1.18402311 |
| 47 | BRSK1 | 1.15698368 |
| 48 | DYRK3 | 1.14411914 |
| 49 | EIF2AK2 | 1.13921661 |
| 50 | MAPKAPK3 | 1.13589507 |
| 51 | CHEK2 | 1.10510400 |
| 52 | NME1 | 1.08111434 |
| 53 | CSNK1G3 | 1.07733628 |
| 54 | MAP3K11 | 1.06082677 |
| 55 | MOS | 1.05165943 |
| 56 | CSNK1G2 | 1.03368653 |
| 57 | CSNK1G1 | 1.00639139 |
| 58 | MAP3K12 | 0.99121915 |
| 59 | NTRK3 | 0.98592922 |
| 60 | MAPK13 | 0.98423088 |
| 61 | MAPKAPK2 | 0.98161536 |
| 62 | CDK19 | 0.97640227 |
| 63 | EPHB1 | 0.97600421 |
| 64 | ACVR1B | 0.96947866 |
| 65 | ATR | 0.91596983 |
| 66 | FLT3 | 0.90446067 |
| 67 | RAF1 | 0.89250398 |
| 68 | STK24 | 0.88790569 |
| 69 | PLK1 | 0.88718113 |
| 70 | PRKCG | 0.85887994 |
| 71 | PRKCE | 0.83453428 |
| 72 | MKNK2 | 0.82620279 |
| 73 | CCNB1 | 0.82241288 |
| 74 | PIM1 | 0.81479050 |
| 75 | SIK3 | 0.80892649 |
| 76 | EIF2AK3 | 0.80491921 |
| 77 | FGFR4 | 0.80242095 |
| 78 | LIMK1 | 0.79205007 |
| 79 | AURKB | 0.75278741 |
| 80 | GRK5 | 0.74869297 |
| 81 | TRPM7 | 0.74866307 |
| 82 | PRKCQ | 0.74851926 |
| 83 | MAPKAPK5 | 0.73880928 |
| 84 | MARK3 | 0.73758854 |
| 85 | PRKCI | 0.73729449 |
| 86 | PNCK | 0.72316210 |
| 87 | PTK6 | 0.72093225 |
| 88 | ADRBK2 | 0.70512423 |
| 89 | PRKAA2 | 0.69807312 |
| 90 | NEK9 | 0.68848360 |
| 91 | AURKA | 0.68436614 |
| 92 | NEK2 | 0.68302230 |
| 93 | PTK2B | 0.66611077 |
| 94 | MAP3K4 | 0.66025125 |
| 95 | KIT | 0.65555670 |
| 96 | INSRR | 0.64540085 |
| 97 | TNK2 | 0.63930951 |
| 98 | FGFR3 | 0.62950330 |
| 99 | JAK2 | 0.62600900 |
| 100 | ADRBK1 | 0.62254530 |
| 101 | KSR2 | 0.61736791 |
| 102 | BMX | 0.61564058 |
| 103 | PLK3 | 0.61490159 |
| 104 | WEE1 | 0.61348519 |
| 105 | PRKCD | 0.60911909 |
| 106 | RPS6KA1 | 0.57681275 |
| 107 | MAP3K1 | 0.57128631 |
| 108 | PLK4 | 0.56533563 |
| 109 | RPS6KA5 | 0.56031661 |
| 110 | PBK | 0.55737387 |
| 111 | BLK | 0.54549007 |
| 112 | BRSK2 | 0.54037878 |
| 113 | TTK | 0.53612203 |
| 114 | MAP2K7 | 0.53438894 |
| 115 | SRPK1 | 0.52693886 |
| 116 | FRK | 0.52559545 |
| 117 | CSNK2A1 | 0.52156758 |
| 118 | PAK3 | 0.51680762 |
| 119 | CSNK2A2 | 0.49793538 |
| 120 | STK39 | 0.49404927 |
| 121 | ERBB3 | 0.48451219 |
| 122 | NTRK1 | 0.47250852 |
| 123 | IRAK3 | 0.46468810 |
| 124 | PRKACA | 0.46132957 |
| 125 | YES1 | 0.44684094 |
| 126 | MAP2K6 | 0.44629426 |
| 127 | TAF1 | 0.44305126 |
| 128 | PRKCZ | 0.43959995 |
| 129 | EPHA4 | 0.43191392 |
| 130 | CDK11A | 0.42703665 |
| 131 | SIK2 | 0.42662566 |
| 132 | PASK | 0.42057040 |
| 133 | MAP4K1 | 0.41915156 |
| 134 | ZAK | 0.40988882 |
| 135 | SGK1 | 0.40878622 |
| 136 | PIK3CA | 0.40246964 |
| 137 | STK11 | 0.39927019 |
| 138 | MST1R | 0.39246371 |
| 139 | MAP2K2 | 0.39219585 |
| 140 | LCK | 0.39182715 |
| 141 | ATM | 0.37158681 |
| 142 | CSF1R | 0.36699508 |
| 143 | MKNK1 | 0.36517339 |
| 144 | RPS6KB2 | 0.35984804 |
| 145 | PRKACB | 0.35697532 |
| 146 | TIE1 | 0.35620498 |
| 147 | EPHA3 | 0.35093444 |
| 148 | AKT1 | 0.33756998 |
| 149 | ABL2 | 0.33331748 |
| 150 | FER | 0.31752322 |
| 151 | DAPK3 | 0.31714905 |
| 152 | LRRK2 | 0.30377881 |
| 153 | BTK | 0.28895772 |
| 154 | TNIK | 0.28850239 |
| 155 | NTRK2 | 0.27200370 |
| 156 | HCK | 0.27134056 |
| 157 | MAP3K3 | 0.26535423 |
| 158 | MAP2K1 | 0.26490706 |
| 159 | MAP3K2 | 0.23746514 |
| 160 | EPHB2 | 0.23578325 |
| 161 | PAK1 | 0.23460193 |
| 162 | WNK1 | 0.22803203 |
| 163 | FGR | 0.22748791 |
| 164 | ABL1 | 0.22616841 |
| 165 | STK4 | 0.22276788 |
| 166 | DYRK1B | 0.21490229 |
| 167 | EGFR | 0.21398938 |
| 168 | GRK6 | 0.21114858 |
| 169 | PLK2 | 0.20925583 |
| 170 | PRKCB | 0.20054421 |
| 171 | MATK | 0.18932833 |
| 172 | IRAK1 | 0.17899040 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 5.35590876 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.41398421 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.81455214 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.50693034 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.23768087 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.11731154 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.91376769 |
| 8 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.54832533 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.46248115 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 2.45044235 |
| 11 | Huntingtons disease_Homo sapiens_hsa05016 | 2.44407353 |
| 12 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.41754742 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.37522685 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.25959889 |
| 15 | Sulfur relay system_Homo sapiens_hsa04122 | 2.22091354 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.02586461 |
| 17 | Base excision repair_Homo sapiens_hsa03410 | 2.02164463 |
| 18 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.97720750 |
| 19 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.95723840 |
| 20 | Protein export_Homo sapiens_hsa03060 | 1.89052343 |
| 21 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.89051815 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.84565414 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.83023209 |
| 24 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.82016124 |
| 25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.79503751 |
| 26 | Proteasome_Homo sapiens_hsa03050 | 1.79238515 |
| 27 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.76442905 |
| 28 | Leishmaniasis_Homo sapiens_hsa05140 | 1.76298544 |
| 29 | DNA replication_Homo sapiens_hsa03030 | 1.71265436 |
| 30 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.68117387 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.59826756 |
| 32 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.56863210 |
| 33 | Mismatch repair_Homo sapiens_hsa03430 | 1.55688143 |
| 34 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.54402680 |
| 35 | Apoptosis_Homo sapiens_hsa04210 | 1.54018783 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 1.49918713 |
| 37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.49608613 |
| 38 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.47460096 |
| 39 | Basal transcription factors_Homo sapiens_hsa03022 | 1.44908036 |
| 40 | RNA degradation_Homo sapiens_hsa03018 | 1.44142344 |
| 41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.43567586 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.42096806 |
| 43 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.40992463 |
| 44 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.40284456 |
| 45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.38124210 |
| 46 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.36683894 |
| 47 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.32708601 |
| 48 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.31019383 |
| 49 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.28534070 |
| 50 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.28299078 |
| 51 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.27312357 |
| 52 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.26647474 |
| 53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.24255618 |
| 54 | Phototransduction_Homo sapiens_hsa04744 | 1.21311890 |
| 55 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.19348223 |
| 56 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.18188618 |
| 57 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.11850253 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 1.05231166 |
| 59 | Asthma_Homo sapiens_hsa05310 | 1.04043579 |
| 60 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.02066498 |
| 61 | Shigellosis_Homo sapiens_hsa05131 | 1.01849324 |
| 62 | Spliceosome_Homo sapiens_hsa03040 | 1.01662824 |
| 63 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.00818793 |
| 64 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.00415570 |
| 65 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.00277084 |
| 66 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.99461502 |
| 67 | RNA transport_Homo sapiens_hsa03013 | 0.97773152 |
| 68 | Legionellosis_Homo sapiens_hsa05134 | 0.97358076 |
| 69 | Purine metabolism_Homo sapiens_hsa00230 | 0.97260644 |
| 70 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.96952598 |
| 71 | Tuberculosis_Homo sapiens_hsa05152 | 0.96005082 |
| 72 | Peroxisome_Homo sapiens_hsa04146 | 0.94598825 |
| 73 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.93037933 |
| 74 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.92322155 |
| 75 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.90492533 |
| 76 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.89569444 |
| 77 | Metabolic pathways_Homo sapiens_hsa01100 | 0.89564847 |
| 78 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.87340495 |
| 79 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.86626812 |
| 80 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.85525210 |
| 81 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.81476242 |
| 82 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.80936245 |
| 83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.78123483 |
| 84 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.78037167 |
| 85 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.77812100 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | 0.77737044 |
| 87 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.76401667 |
| 88 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.75979448 |
| 89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.75754113 |
| 90 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.73385650 |
| 91 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.71746673 |
| 92 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.70125286 |
| 93 | Hepatitis B_Homo sapiens_hsa05161 | 0.70116326 |
| 94 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.69392954 |
| 95 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.69047530 |
| 96 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.68623839 |
| 97 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.67766427 |
| 98 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.67490264 |
| 99 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.66713096 |
| 100 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.65535337 |
| 101 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63252204 |
| 102 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.63096191 |
| 103 | Salmonella infection_Homo sapiens_hsa05132 | 0.60684131 |
| 104 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.60532319 |
| 105 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60512062 |
| 106 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.60415903 |
| 107 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.60292034 |
| 108 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.60071851 |
| 109 | Cocaine addiction_Homo sapiens_hsa05030 | 0.58222990 |
| 110 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.56696626 |
| 111 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.56530042 |
| 112 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.55063889 |
| 113 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.54062858 |
| 114 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.53241301 |
| 115 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.52938068 |
| 116 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.51573600 |
| 117 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.50904435 |
| 118 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.49942332 |
| 119 | Parkinsons disease_Homo sapiens_hsa05012 | 0.49873798 |
| 120 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.49582965 |
| 121 | Olfactory transduction_Homo sapiens_hsa04740 | 0.49273112 |
| 122 | Phagosome_Homo sapiens_hsa04145 | 0.47705802 |
| 123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46224999 |
| 124 | Malaria_Homo sapiens_hsa05144 | 0.46064849 |
| 125 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.45978175 |
| 126 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.45555470 |
| 127 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.45390764 |
| 128 | Renin secretion_Homo sapiens_hsa04924 | 0.45123878 |
| 129 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44980839 |
| 130 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44919483 |
| 131 | Ribosome_Homo sapiens_hsa03010 | 0.44777714 |
| 132 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.44752726 |
| 133 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.44371958 |
| 134 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.43516730 |
| 135 | Alzheimers disease_Homo sapiens_hsa05010 | 0.43367498 |
| 136 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.43014756 |
| 137 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41812417 |
| 138 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.41454370 |
| 139 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.40795435 |
| 140 | Taste transduction_Homo sapiens_hsa04742 | 0.40651118 |
| 141 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.39553201 |
| 142 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.39310395 |
| 143 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.39160045 |
| 144 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.38727533 |
| 145 | Nicotine addiction_Homo sapiens_hsa05033 | 0.38720038 |
| 146 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36824936 |
| 147 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36683636 |
| 148 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.36426098 |
| 149 | Morphine addiction_Homo sapiens_hsa05032 | 0.36320907 |
| 150 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.36062756 |
| 151 | HTLV-I infection_Homo sapiens_hsa05166 | 0.33738075 |
| 152 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32651870 |
| 153 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.32439417 |
| 154 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.31225583 |
| 155 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.30592978 |
| 156 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.30199584 |
| 157 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.29251161 |
| 158 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.28969110 |
| 159 | Circadian entrainment_Homo sapiens_hsa04713 | 0.28220604 |
| 160 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.27847376 |
| 161 | Retinol metabolism_Homo sapiens_hsa00830 | 0.27646136 |
| 162 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.26264248 |
| 163 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.25621247 |
| 164 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.25502199 |
| 165 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.25448941 |
| 166 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.25325316 |
| 167 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.24569539 |
| 168 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.24424054 |
| 169 | Amoebiasis_Homo sapiens_hsa05146 | 0.24359797 |
| 170 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.23118162 |
| 171 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.22652815 |
| 172 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.22300138 |
| 173 | GABAergic synapse_Homo sapiens_hsa04727 | 0.22143246 |
| 174 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.21903149 |
| 175 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.20306371 |
| 176 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.20017024 |
| 177 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.18362718 |
| 178 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.17754091 |

